Abstract
Proteases are required to generate active peptide neurotransmitters, known as neuropeptides, from pro-neuropeptides. Model animal systems have recently illustrated roles for the cathepsin V (CTSV) and cathepsin L (CTSL) cysteine proteases, combined with the serine proteases PC1/3 (PCSK1) and PC2 (PCSK2), and exopeptidases in the production of neuropeptides. There is notable interest in the human-specific cathepsin V gene which is not present in rodent and other animal models used in prior studies of neuropeptide production. A gap in the field is knowledge of the human brain gene expression patterns of these neuropeptide-producing protease systems. Therefore, the goal of this study was to characterize the expression profiles of these pro-neuropeptide processing proteases in human brain. Quantitative gene expression microarray data for 169 human brain regions was obtained from the Allen Institute Human Brain Atlas resource, analyzed as log2 of gene expression intensity normalized to the mean of human genes (21,245 genes) expressed in human brain. These proteases had log2 values of 2–12, indicating expression levels above the average of all genes in the human brain, with varying expression levels among the 169 brain regions. CTSV and CTSL displayed moderate to high expression values of 1.9–8.6 and 7.1–10.6, respectively. Interestingly, CTSV and CTSL showed high expression in white matter composed of myelinated axons, consistent with the knowledge that neuropeptide production occurs in axons within transported neuropeptide secretory vesicles to nerve terminals. PCSK1 had a broad range of moderate to very high expression with log2 of 2–12. PCSK2 had somewhat lower expression levels than PCSK1. The exopeptidase genes RNPEP, CTSH, and CPE each showed fairly even levels of expression throughout the brain, with CPE displaying high expression. The prevalence of these processing proteases throughout human brain regions, including areas rich in neuropeptides such as hypothalamus, is consistent with their roles for neuropeptide production. Further, proenkephalin and NPY precursors, substrates of CTSV and CTSL shown in prior model animal studies, were co-expressed with CTSV and CTSL. These data demonstrate that the human brain expresses the neuropeptide-producing cysteine and serine proteases, with exopeptidases, throughout a multitude of brain regions.
Highlights
Neuropeptides are essential as neurotransmitters and neurohumoral effectors for cellcell communication in the brain and neuroendocrine systems (Krieger et al, 1983; Palkovits, 2002; Kastin, 2006)
Expression analyses of cysteine and serine protease pathway genes involved in neuropeptide production
This study evaluated the human brain gene expression profiles of the neuropeptideproducing proteases consisting of the cathepsin V (CTSV) and cathepsin L (CTSL) cysteine proteases, the PCSK1 and PCSK2 serine proteases, and the exopeptidases residues by aminopeptidase B (RNPEP), cathepsin H (CTSH), and carboxypeptidase E (CPE)
Summary
Neuropeptides are essential as neurotransmitters and neurohumoral effectors for cellcell communication in the brain and neuroendocrine systems (Krieger et al, 1983; Palkovits, 2002; Kastin, 2006). Neuropeptides represent the largest class of neurotransmitters, and function together with the small classical neurotransmitter molecules (Siegel et al, 1999). Diverse neuropeptides are expressed in virtually all brain regions, and they participate in a wealth of brain functions. The opioid neuropeptides enkephalin, b-endorphin, and dynorphin regulate analgesia and are important in chronic pain conditions (Inturrisi, 2002; Charbogne et al, 2014; Podvin et al, 2016). Diverse neuropeptides participate in brain functions in health and in neurological diseases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.